Role of mitophagy in treatment of muscular dystrophy by SIRT1 activation
| Project/Area Number |
17K15582
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General pharmacology
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2017-04-01 – 2019-03-31
|
| Project Status |
Completed (Fiscal Year 2018)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | SIRT1 / オートファジー / マイトファジー / 筋ジストロフィー / 骨格筋・平滑筋 |
|---|
| Outline of Final Research Achievements |
We found that SIRT1 is involved in the activation of mitophagy and involved in the fusion of lysosomes with damaged mitochondria that are isolated by autophagosomes during mitophagy in skeletal muscle-specific SIRT1 knockout mice and C2C12 myoblasts. Furthermore, we revealed that damaged mitochondria with deleted mitochondrial DNA was accumulate in mdx skeletal muscle. This result indicate that mitophagy-mediated mitochondrial clearance is reduced in skeletal muscle of mdx mice.
In this study, we showed that skeletal muscle SIRT1 exhibits a muscle protective effect through mitophagy activation.
|
| Academic Significance and Societal Importance of the Research Achievements |
本研究の結果から、SIRT1活性化を介したマイトファジーの促進が筋ジストロフィーの治療標的となる可能性が示唆された。さらに、SIRT1が骨格筋においてオートファジーの制御を介して保護的に働いていることが明らかとなった。本研究によってSIRT1の活性化は筋ジストロフィー以外の筋疾患治療法の開発にも結びつく可能性が示された。
|
Report
(3 results)
Research Products
(15 results)
